Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)
Timothy M. E. Davis(Liberty University), Rury R. Holman(University of Oxford), Alex Wright(NIHR Surgical Reconstruction and Microbiology Research Centre), Irene Stratton(Cheltenham General Hospital), C A Cull(Churchill Hospital), Emanuele Bosi(Vita-Salute San Raffaele University), Z Mehta(University of Oxford), G. F. Bottazzo(Bambino Gesù Children's Hospital)
Cited by 116
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k